O'Brien, Virginia C.2022-02-092022-02-092019-09-24http://hdl.handle.net/10919/108240Cancer-related cognitive impairment (CRCI) is a common side effect of cancer and its treatment that can significantly impact patients' quality of life. CRCI may arise before, during or after cancer treatment, but for up to 30% of patients, CRCI persists1. The etiology of CRCI is hypothesized to be due to direct cytotoxic effects, oxidative stress, and/or the body's immune response to cancer and its treatment. This lack of certainty surrounding the cause of CRCI makes identification of appropriate interventions challenging. Persistent CRCI can significantly impact patients' role functioning, thus treating the symptoms of CRCI is paramount to comprehensive cancer care.application/pdfenIn CopyrightPoster2022-02-09